In a significant milestone for autoimmune disease research, argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative...
Read MoreEdinburgh-based biotech company Cytomos has announced a significant milestone, raising $5m (approximately £3.98m) in an oversubscribed funding round to...
Read MoreTeva Pharmaceuticals and Immunai, a leader in artificial intelligence (AI)-driven immune system mapping, have announced a groundbreaking multi-year partnership...
Read MoreOsivax, a pioneering biopharmaceutical company, has achieved a significant milestone by vaccinating the first participant in its Phase 2a...
Read MoreAC Immune SA has announced encouraging interim results from its ongoing Phase 2 VacSYn clinical trial of ACI-7104.056, an...
Read MoreIn a significant step forward for bladder cancer treatment, Johnson & Johnson announced that the UK’s Medicines and Healthcare...
Read More